Novel cancer therapy targeting microbiome.

Nagano, Tatsuya; Otoshi, Takehiro; Hazama, Daisuke; Kiriu, Tatsunori; Umezawa, Kanoko; Katsurada, Naoko; Nishimura, Yoshihiro

Nagano, Tatsuya; Otoshi, Takehiro; Hazama, Daisuke; Kiriu, Tatsunori; Umezawa, Kanoko; Katsurada, Naoko; Nishimura, Yoshihiro.

Afiliación

Nagano T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Otoshi T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Hazama D; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kiriu T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Umezawa K; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Katsurada N; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Nishimura Y; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Onco Targets Ther ; 12: 3619-3624, 2019.

Article en En | MEDLINE | ID: mdl-31190864

Palabras clave

antibiotics; dysbiosis; prebiotics; probiotics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google